Our previous research demonstrated that MTRasym values from APTWI could differentiate four molecular subtypes of breast cancer, with certain trends: TN breast cancer exhibited the highest MTRasym values, followed by HER2‐enriched and Luminal B, while lower MTRasym values were more inclined to Luminal A (see Table S1). This evidence concerns the gene ERBB2 and breast carcinoma.